Aptevo Therapeutics Inc.
Hedge Funds Holdings
Last updated:
Aptevo Therapeutics Inc.‘s stocks are currently a part of 12 hedge funds’ portfolios, which represents 2.93% of the total amount of its stocks outstanding. This makes up a total of 149.25K shares of Aptevo Therapeutics Inc.. Compared to the previous quarter, the number fell by -84.50% or -813.99K shares fewer. As for the holding position changes, 8.33% (1) of current hedge fund investors increased the number of shares held, 25% (3) of current holders sold a part of the shares held, and 25% (3) closed the holdings completely. 2 hedge funds are new holders of Aptevo Therapeutics Inc. stock in Q1 2023, it is 16.67% of total holders.
Hedge funds holding Aptevo Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 58 |
|---|---|
| Q3 2018 | 53 |
| Q4 2018 | 44 |
| Q1 2019 | 45 |
| Q2 2019 | 41 |
| Q3 2019 | 38 |
| Q4 2019 | 31 |
| Q1 2020 | 15 |
| Q2 2020 | 18 |
| Q3 2020 | 17 |
| Q4 2020 | 35 |
| Q1 2021 | 32 |
| Q2 2021 | 25 |
| Q3 2021 | 21 |
| Q4 2021 | 18 |
| Q1 2022 | 18 |
| Q2 2022 | 20 |
| Q3 2022 | 20 |
| Q4 2022 | 26 |
| Q1 2023 | 12 |
Hedge funds changes in Aptevo Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 14 | 16 | 14 | 5 | 9 |
|---|---|---|---|---|---|
| Q3 2018 | 4 | 8 | 19 | 9 | 13 |
| Q4 2018 | 5 | 11 | 13 | 14 | 1 |
| Q1 2019 | 12 | 6 | 7 | 11 | 9 |
| Q2 2019 | 7 | 10 | 8 | 11 | 5 |
| Q3 2019 | 4 | 9 | 9 | 7 | 9 |
| Q4 2019 | 3 | 6 | 7 | 9 | 6 |
| Q1 2020 | 15 | 0 | 0 | 31 | -31 |
| Q2 2020 | 5 | 4 | 4 | 3 | 2 |
| Q3 2020 | 4 | 3 | 5 | 5 | 0 |
| Q4 2020 | 23 | 5 | 4 | 5 | -2 |
| Q1 2021 | 6 | 9 | 12 | 9 | -4 |
| Q2 2021 | 5 | 9 | 4 | 12 | -5 |
| Q3 2021 | 4 | 5 | 3 | 7 | 2 |
| Q4 2021 | 5 | 2 | 4 | 8 | -1 |
| Q1 2022 | 4 | 3 | 6 | 4 | 1 |
| Q2 2022 | 4 | 4 | 8 | 2 | 2 |
| Q3 2022 | 4 | 5 | 3 | 4 | 4 |
| Q4 2022 | 9 | 4 | 8 | 3 | 2 |
| Q1 2023 | 2 | 1 | 3 | 3 | 3 |
Hedge funds changes in Aptevo Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 675,000 | 0 |
| Q2 2019 | 665,000 | 0 |
| Q3 2019 | 441,000 | 0 |
| Q4 2019 | 491,000 | 0 |
| Q1 2020 | 2,775,000 | 0 |
| Q2 2020 | 5,394,000 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 19,646,000 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 0 | 0 |
| Q1 2022 | 0 | 0 |
| Q2 2022 | 0 | 0 |
| Q3 2022 | 0 | 0 |
| Q4 2022 | 0 | 0 |
| Q1 2023 | 0 | 0 |
Top 50 hedge fund holders of Aptevo Therapeutics Inc. (NASDAQ:APVO)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| VANGUARD GROUP INC | 726K | 238.84K | 0.000% |
| SCHONFELD STRATEGIC ADVISORS LLC | 447K | 146.9K | 0.004% |
| CANTOR FITZGERALD, L. P. | 406K | 133.7K | 0.009% |
| RENAISSANCE TECHNOLOGIES LLC Jim Simons | 208K | 68.38K | 0.000% |
| GEODE CAPITAL MANAGEMENT, LLC | 161K | 52.96K | 0.000% |
| BLACKROCK INC. Larry Fink | 146K | 48.04K | 0.000% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 141K | 46.2K | 0.000% |
| VIRTU FINANCIAL LLC | 86K | 28.42K | 0.008% |
| BANK OF NEW YORK MELLON CORP | 63K | 20.69K | 0.000% |
| MORGAN STANLEY | 57K | 18.81K | 0.000% |
| NORTHERN TRUST CORP | 53K | 17.51K | 0.000% |
| CITADEL ADVISORS LLC Ken Griffin | 51K | 16.77K | 0.000% |
| FRANKLIN RESOURCES INC | 33K | 10.99K | 0.000% |
| STATE STREET CORP | 33K | 10.94K | 0.000% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 9K | 2.80K | 0.000% |
| BANK OF AMERICA CORP /DE/ | 6K | 1.94K | 0.000% |
| WELLS FARGO & COMPANY/MN | 5K | 1.72K | 0.000% |
| ROYAL BANK OF CANADA | 2K | 714 | 0.000% |
| UBS GROUP AG | 1K | 430 | 0.000% |
| FIFTH THIRD BANCORP | 1K | 291 | 0.000% |
| BARCLAYS PLC | 0 | 0 | 0.000% |
| VERITABLE, L.P. | 0 | 0 | 0.000% |
| FMR LLC | 0 | 0 | 0.000% |
| PNC FINANCIAL SERVICES GROUP, INC. | 0 | 0 | 0.000% |